Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Leiomyosarcoma × Dacarbazine × Clear all

Phase

Status

Completed 5 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 8 Hodgkin Disease 5 Lymphoma 3 Thyroid Neoplasms 1 Sarcoma 1 Recurrence 1 Neoplasm Metastasis 1 Leiomyosarcoma 1 Carcinoma, Medullary 1

Interventions

Trabectedin 2 Doxorubicin 2 rucaparib 1 pembrolizumab 1 pazopanib 1 itacitinib 1 baricitinib 1 avelumab 1 TTI-621 1 PTC596 1 Letrozole 1 Ifosfamide 1 INCB039110 1 Docetaxel 1 Dacarbazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05269355 2025-06-13

SUNRISELMS

PTC Therapeutics

Phase 2/3 Terminated

359 enrolled 15 charts

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡